• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ARDS

ARDS

Aridis Pharmaceuticals, Inc.

OTCHealthcareBiotechnologyUS

USD0.00

+0.00 (+0.00%)

Company Profile

CEO

Vu L. Truong

IPO Date

2018-08-14

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

Country

US

Market Metrics

Open

$0.00

Prev. Close

$0.00

Day Low

$0.00

Day High

$0.00

52W Low

$0.00

52W High

$0.05

Market Cap

$0.00B

Volume

0.00M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

48.0%

Avg Negative

1.6%

Avg Neutral

50.3%

News Feed

Analysts Estimate ARIDIS PHARMACT (ARDS) to Report a Decline in Earnings: What to Look Out for

Zacks Investment Research·8/3/2021·↑ positive

Aridis Pharmaceuticals Announces $25 Million Registered Direct Offering Priced at a Premium to Market

PRNewsWire·8/2/2021·↑ positive

Aridis Pharmaceuticals' COVID mAb Ranks Among the Top 5 Most Potent COVID-19 mAbs Evaluated by the Coronavirus Immunotherapeutics Consortium (CoVIC)

PRNewsWire·7/26/2021·↑ positive

Aridis Pharma's COVID-19 Antibody Neutralizes Delta Variant In Animal Model

Benzinga·7/13/2021·↑ positive

Aridis Pharmaceuticals COVID mAb AR-712 Neutralizes SARS-CoV-2 Delta Variant

PRNewsWire·7/12/2021·↑ positive

Strength Seen in ARIDIS PHARMACT (ARDS): Can Its 10% Jump Turn into More Strength?

Zacks Investment Research·6/9/2021·↑ positive

Aridis Pharmaceuticals Announces First Quarter 2021 Results

PRNewsWire·5/11/2021·↑ positive

CORRECTING and REPLACING Kermode Biotechnologies Announced that it is Actively Engaged in Discovery to Identify the Mode of Transmission for the African Swine Fever Virus (ASFV)

Business Wire·4/27/2021·↑ positive

Kermode Biotechnologies Announced that it is Actively Engaged in Discovery to Identify the Mode of Transmission for the African Swine Fever Virus (ASFV)

Business Wire·4/27/2021·↑ positive

Aridis Pharmaceuticals Announces 2020 Fourth Quarter and Year-End Financial Results and Business Update

PRNewsWire·3/30/2021·↑ positive